Oxidation of human low-density lipoprotein (LDL) was found to be accompanied by the generation of various reactive aldehydes. One of them, 4-hydroxynonenal (HNE), was shown to modify LDL to a form which represents a good model of oxidized LDL (ox-LDL). In order to investigate the epitopes newly formed on HNE-modified LDL, a polyvalent antiserum to HNE-LDL [anti-(HNE-LDL)] was raised in rabbits and the non-specific components were removed with native LDL coupled to CNBr-Sepharose 4B. Competitive fluorescence immunoassay analysis showed that anti-(HNE-LDL) recognized HNE-LDL, copper-oxidized LDL, HNE-albumin and to a lower extent HNE-modified high-density lipoprotein 3 (HNE-HDL3) and ox-HDL3 but not native LDL. A certain degree of cross-reactivity of the antibody with LDLs modified by either hexanal or 2,4-heptadienal was found. No reaction was obtained with LDL labelled with malondialdehyde. From the abilities of HNE-modified poly(L-amino acids) to compete with HNE-LDL for binding to anti-(HNE-LDL), it is postulated that lysine, tyrosine, arginine and histidine are involved in the formation of HNEderived epitopes on apolipoprotein B (apo B). Using a double-sandwich fluorescence immunoassay [capture antibody: anti-(apo B); detection antibody: anti-(HNE-LDL)] we found that the HNE-derived epitopes were expressed at a far higher degree in ox-LDL and HNE-LDL than in native LDL.
INTRODUCTION
It is well known that elevated plasma levels of low-density lipoprotein (LDL) are associated with accelerated atherosclerosis. The mechanism for the action of LDL in atherosclerosis in vivo is not clear but several lines of evidence indicate that oxidatively modified LDL (ox-LDL) might play a significant role in atherogenesis [1] [2] [3] [4] . Ox-LDL is able to cause accumulation of large amounts of cholesteryl esters in macrophages which is characteristic for early atherosclerotic lesions. Ox-LDL is highly cytotoxic, facilitates the recruitment and the retention of monocyte macrophages in vitro and in this way it might contribute to the progression of early fatty-streak lesion to the more complicated lesion in vivo. Antioxidants such as probucol, which have the ability to protect LDL from oxidation, were shown to prevent the progression of atherosclerosis in Watanabe-heritablehyperlipidaemic rabbits [5, 6] .
LDL oxidation is a complex process which is initiated by a free-radical lipid-peroxidation mechanism [2] . Experiments in vitro show that oxidation can be promoted by endothelial cells [7] , smooth-muscle cells [8] , monocytes and macrophages [9] , as well as bivalent transition-metal ions such as copper or iron [10] . During the oxidative degradation of polyunsaturated fatty acids in LDL, a variety of reactive aldehydic products are generated which are capable of attaching covalently to apolipoprotein B (apo B). 4-Hydroxynonenal (HNE) is one of these major products. Compared with malondialdehyde (MDA), another major aldehyde product formed in LDL during oxidation, the concentration of HNE within the LDL particle is higher, even though its total production during the process of LDL oxidation is lower [11] . Studying the modification of LDL with certain aldehydes derived from lipid peroxidation of polyunsaturated fatty acids, Juirgens et al. [12] showed that HNE was incorporated into LDL more rapidly than MDA in vitro. Thus HNE-modified LDL (HNE-LDL) became a subject of closer investigation.
HNE-LDL showed decreased binding affinity to LDL receptors on human fibroblasts [13] and led to an overload of lipids in macrophages [14] . HNE-derived epitopes were found to exist not only on ox-LDL since they were also expressed on oxidized verylow-density lipoprotein and lipoprotein (a) [15] . Recently, Palinski et al. [16] developed polyvalent and monoclonal antibodies to reduced (by cyanoborohydride) HNE-LDL. These antibodies reacted with HNE-lysine conjugates on apo B and a positive immunostaining was obtained in the atherosclerotic lesions of WHHL rabbits [17] . Rosenfeld et al. [18] demonstrated that macrophage-derived foam cells within sections of the atherosclerotic lesions from the ballooned rabbit exhibit positive immunoreactivity with HNE-lysine-specific antibodies. Since it is not clear if reducing conditions during a reaction of HNE with apo B will occur in vivo and if lysine is the only amino acid residue involved in the attaching of HNE to the apo B molecule, we used human HNE-LDL modified under non-reducing conditions to immunize rabbits for production of an antiserum. This paper describes the specificity of this antiserum. Secondly, the immunochemical properties of HNE-derived epitopes formed during the LDL modification are compared with the epitopes derived from other aldehydes. Thirdly, certain HNE-modified poly(L-amino acids) were tested with a competitive fluorescence immunoassay to estimate their potential roles in the HNE modification. Finally, we compared the amount of HNE-derived epitopes on native LDL with ox-LDL and HNE-LDL by a double-sandwich fluorescence immunoassay. [19] with BSA (Sigma) as the standard.
Modification of the lipoproteins HNE was synthesized as described previously [20] . MDA was obtained by acid hydrolysis of 1,1,3,3-tetraethoxypropane [21] and its content was measured as described [22] . Hexanal and 2,4-heptadienal were supplied by Aldrich (Steinheim, Germany). After extensive dialysis against N2-saturated 0.1 M-phosphatebuffered saline (PBS), pH 7. Briefly, 10 mg of native LDL was coupled to about 2 ml of swollen CNBr-activated Sepharose 4B as described in the instruction manual (Affinity Chromatography; Principles and Methods; Pharmacia LKB Biotechnology, S-75182 Uppsala, Sweden) except that 0.1 mg of EDTA/ml was added to the working buffer. Then 1 ml of antiserum was incubated with 0.3 ml of LDL-coupled CNBr-Sepharose 4B under N2 at room temperature for 3 h and the supernatant was collected. The same procedure was repeated three times with the fresh antigencoupled gels and the purification efficiency was monitored by a competitive fluorescence immunoassay.
Solid-phase fluorescence immunoassay For the binding assay, poly(vinyl chloride) microtitration plates (A/S Nunc, Roskilde, Denmark) were coated with 200 1dl of HNE-LDL (1 ,tg/ml) in 50 mM-sodium carbonate buffer (pH 9.6) containing 1 mg of EDTA/ml at 4°C overnight. After they had been washed once with washing buffer (50 mM-Tris/HCl buffer, pH 7.7, containing 9 g of NaCl/l, 0.2 g of Tween 20/1 and 0.5 g of NaN3/l) using a microtitration plate washer (Wallac Oy, Turku, Finland), 250 ,ul of blocking buffer [50 mMNaH2PO4 H20, 5 g of BSA/I and 60 g of sorbitol/l (Sigma)] was added to the wells to block the remaining binding sites. The wells were then washed twice and 200 ,ul of serial dilutions of antiserum were plated and incubated for 2 h at room temperature. After three washes, the amount of rabbit IgG bound was detected by adding 50 ng of a goat anti-rabbit IgG (Sigma) labelled with europium (DELFIA, Eu-labelling kit 1244-302, Pharmacia) per well according to the manufacturer's description. The labelling yield was 10 Eu3+/IgG (mol/mol). After incubation for 1 h at room temperature, the plates were washed six times. Then 200 ,ul of enhancement solution (Pharmacia)/well was added to measure the fluorescence counts in the well with a 1234 DELFIA research fluorimeter (Wallac Oy). The titre of the antibody was defined as the reciprocal of the greatest dilution of the antiserum that gave a specific binding three times greater than the normal rabbit serum used as a blank.
Competitive solid-phase fluorescence immunoassays were performed similarly, except that 100,u of fixed dilution of the primary antibody was added together with an equal volume of assay buffer [50 mM-Tris/HCl buffer, pH 7.7, containing 5 g of BSA/I, 0.5 g of bovine globulin/l (Sigma), 0.5 g of NaN3/l, 8 mg of diethylenetriaminepenta-acetic acid (Sigma)/l, 9 g of NaCl/l and 100tld of Tween 
RESULTS

Characteristics of the antiserum to human HNE-LDL
When human HNE-LDL was used to immunize rabbits, the antiserum produced contained components non-specific for HNE adducts since human LDL is heterologous to rabbit. In order to get rid of these non-specific components, we applied the rabbit antiserum to a CNBr-Sepharose 4B column to which native human LDL was coupled. During the process of antiserum purification the ability of native human LDL to compete with HNE-LDL for binding to the antiserum decreased gradually along with the titres of antibody when monitored by the fluorescence immunoassay (results not shown). Fig. l(a) shows the binding properties of anti-(HNE-LDL) to HNE-modified human LDL after purification of the antibody by affinity chromatography. Fig. l(b) Competitor (ug/well) reactive short-chain aldehydes were generated and some of them could covalently attach to apo B [11] . The immunochemical relationship between LDL modified by HNE and LDLs modified by the three other important aldehydes was investigated (Fig. 3) . MDA was selected since it was generated during LDL oxidation in quantities comparable with HNE and our earlier experimental data demonstrated that 930% of MDA is distributed in the aqueous phase. In contrast, 98 % of 2,4-heptadienal remained within the lipid phase of LDL. The aldehyde generated at the highest concentration during LDL oxidation was hexanal [11] . As shown in Fig. 3 , only MDA-LDL does not compete with HNE-LDL for binding to the anti-(HNE-LDL) antibody, whereas the LDLs modified with 2,4-heptadienal and hexanal in part do.
Since the inability of MDA-LDL to compete with HNE-LDL for the antibody could be the result of not enough modification, we compared the relative electrophoretic mobilities, amounts of reactive amino groups and native apo B epitopes on LDLs modified by the different aldehydes (Table 2) . Of the four modified LDLs tested, the MDA-modified LDL showed the highest degree of modification as expressed by its relative electrophoretic mobility. MDA-LDL also lost the most reactive amino groups. However, the amounts of native apo B epitopes left on MDA-LDL are similar to those on HNE-LDL.
Evaluation of the amino acid residues involved in the formation of HNE-derived epitopes on apo B
As an approach to exploring which amino acid residues are involved in the modification of apo B by HNE, five poly(L-amino acids) were incubated with HNE under different pH conditions ( Table 1 ). The increased relative electrophoretic mobilities of HNE-poly(L-lysine) and HNE-poly(L-arginine) were measured by agarose-gel electrophoresis but those of the others could not be estimated because they were not present in the system used (Lipidophor). Both untreated and HNE-treated poly(L-amino Table 3 . Levels of HNE-derived epitopes on isolated LDL Goat anti-(human apo B) (200 ng) was used for coating the wells. After the unspecific binding sites had been blocked (see the Materials and methods section), 100 #1 of rabbit anti-(HNE-LDL) serum (diluted 1000-fold with the assay buffer) and 100 ,ul of each sample were incubated in the wells to determine HNE-derived epitopes on apo B. In parallel, 100 #1 of rabbit anti-(apo B) serum (diluted 10000-fold) and 100 ,ul of each sample were incubated in the relevant wells to measure the levels of apo B. Europium-labelled goat antirabbit IgG (50 ng) was used as the detection antibody. acids) were tested in a competitive fluorescence assay. As depicted in Fig. 4 , all untreated poly(L-amino acids) were unable to compete with HNE-LDL for binding to anti-(HNE-LDL) except -poly(L-tyrosine) (the-maximum competitive inhibition in the experiment was 24-%). If theconcentra:ion of the competitor is fixed, the ranking of the tested HNE-poly(L-amino acids) is as follows: HNE-poly(L-lysine).> HNE-poly(L-tyrosine) > HNEpoly(L-arginine) > HNE-poly(L-histidine) (Table 1) , although the maximum competiti&e inhibitioon of HNE-poly(L-lysine) (70 %) is lower than that of QE7po-ly(Ayresine) (83 %). HNEpoly(L-proline) does notfcompete with HNE-LDL for binding to anti-(HNE-LDL).
Measurement of -HE v q es a B
A double-antibody-sanadwicbhtorescence immunoassay was established to,measure-the LIE-derived epitopes on apo B. In order to focus on the modification ofthe aidehyde on apo B, we used a goat anti-(human po B) atibody as the capture antibody.
Since the level of apo B in the tcsted samples could interfere with the results, the apo B concentration was determined as well as the concentrations of HNE-drived epitopes in the same sample at the same time; The final result was expressed as the ratio of HNE-derived epitope/apo B. Table 3 gives data for isolated LDL. The ratio, of HNE-derived epitope/apo B from HNE-LDL was 100-fold higher than that of native LDL. Ox-LDL (copperinduced for 24 h) had the highest ratio.
DISCUSSION
It is well known that during oxidation of LDL a lot of reactive aldehydic products are generated and many of them can attach covalently to apo B [11] . The use of antibodies against these oxidation-specific aldehyde epitopes has accelerated the progress of studies on the atherogenicity of ox-LDL [15, 17, 18, [25] [26] [27] . The antibody used in this paper could recognize HNE-LDL and ox-LDL but not native LDL, as demonstrated by competitive fluorescence immunoassay (Fig. lb) . This is consistent with our earlier results obtained using an agarose double-immunodiffusion test [15] . Further tests showed that not only HNE-LDL but also other HNE-modified proteins (e.g. HNE-HDL3, HNE-albumin) could be recognized by the antibody, suggesting that this antibody is specific for HNE-derived epitopes regardless of the origin of the protein. This result is similar to our earlier report [15] and the data reported by Palinski et al. [16] on a monoclonal antibody to 4-HNE-reduced LDL which recognized 4-HNE-reduced LDL as well as 4-HNE-reduced albumin.
In order to characterize the specificity of anti-(HNE-LDL) in more detail, we compared the binding abilities of the LDLs modified by four kinds of aldehyde to anti-(HNE-LDL). A slight cross-reactivity of anti-(HNE-LDL) with 4-hydroxyoctenal had been found earlier [15] . However, unexpectedly, LDLs modified by 2,4-heptadienal and hexanal could also compete with HNE-LDL for binding to the antibody whereas MDA-LDL could not, which is in agreement with previous results [15] (Fig. 3) . This might be due to the fact that MDA, as a bivalent aldehyde, might react in a completely different manner from univalent aldehydes, such as HNE, hexanal and 2,4-heptadienal, with certain residues on apo B.
Furthermore, we wanted to investigate more closely which amino acid residues apart from lysine are involved in the formation of HNE-derived epitopes on apo B. We approached this by modifying several poly(L-amino acids) with HNE and used these products as competitors for the binding of HNE-LDL to anti-(HNE-LDL) in a fluorescence immunoassay. We found that HNE-poly(L-lysine), HNE-poly(L-tyrosine), HNE-poly(Larginine) and HNE-poly(L-histidine) (to a minor extent) were able to compete. The HNE-modified poly(L-amino acids) did not completely inhibit the binding of the antibody to HNE-LDL even when the concentration of the competitors was raised or different competitors were combined (results not shown). One possible explanation might be that modification of LDL by HNE leads to changes in the folding of apo B on the surface of LDL. Therefore our polyclonal antiserum to HNE-LDL might also contain antibodies directed against epitopes of apo B that were buried in the lipid shell before modification of LDL and might not contain HNE. Thus it seems to be impossible to block completely the binding of anti-(HNE-LDL) to HNE-LDL by HNE-derived epitopes formed on the polymers of amino acids.
Analysing the amino acid composition of HNE-LDL, Jiirgens et al. [28] proved that, after modification of LDL by HNE, the contents of lysine, tyrosine, serine and histidine residues were decreased; Fong et al. [29] found that cooper-ion-induced oxidation of LDL resulted in a consistent decrease in histidine, lysine and proline residues. However, in our experiments HNEpoly(L-proline) had no ability to bind to anti-(HNE-LDL). Since the aliphatic side chain of proline has no functional groups, it probably cannot interact with HNE. As nucleophiles, however, arginine, lysine and histidine are good targets for attack by electrophilic compounds. such as HNE. As to tyrosine, the hydroxy group on the phenolic ring possibly takes part in the reaction. The competitive ability of poly(L-serine) could not be tested since the polymer was not soluble in any buffers used [23] . To summarize, lysine, tyrosine, arginine and histidine residues are the likely candidates for interaction of apo B with HNE.
The susceptibility of LDL to oxidation might be an important factor in atheroscelerosis, and several methods have been developed for assaying it [11] . The most commonly used assays are based on the determination of thiobarbituric acid-reactive substances or conjugated dienes [11, 30] . However, the methodology of measuring the oxidation of LDL still needed to be improved because thiobarbituric acid-reactive substances represent only minor products in ox-LDL and there is only a poor correlation with the final products of lipid peroxidation [31] . Therefore a sandwich fluorescence immunoassay was established. In order to evaluate HNE-derived epitopes independently of the concentration of apo B, the latter was measured concomitantly with the determination of the HNE-derived epitopes. It is worth mentioning that the ratio of HNE-derived epitope/native apo B in the assay does not represent either the absolute amount of HNE-derived epitopes on apo B or the percentage of modified apo B in the native apo B because the concentration of standard HNE-LDL used in the assay was expressed as the protein concentration before modification. However, the changes assayed Vol. 288 Q. Chen, H. Esterbauer and G. Jurgens would reflect the degree of oxidative modification with regard to the protein moiety. The data in Table 3 demonstrate that the number of HNE-derived epitopes on HNE-LDL, as recognized by our anti-(HNE-LDL), is more than 100-fold higher than that of native LDL. The highest amount of HNE-derived epitopes was found on ox-LDL.
The concept that oxidative modification of LDL takes place in vivo has been suggested by several authors, although most of them stressed this in relation to the cells and blood vascular walls [17, 18, [25] [26] [27] . However, Salmon et al. [32] described an e.l.i.s.a. technique able to recognize MDA-LDL in the serum of patients with cardiovascular diseases; Parums et al. [33] showed that antibodies to ox-LDL were detected in sera of 20 patients with clinical chronic periaortitis but not in healthy young adults. These findings are in agreement with a recently published article showing a strong correlation of autoantibodies against MDA-LDL with progression of carotid atherosclerosis in Finnish men [34] . Avogaro et al. [35, 36] and Shimano et al. [37] isolated a small more-electronegative LDL in human plasma. The crucial point, however, is to develop an assay by which a possible modified LDL can be directly detected and measured in serum in order to avoid generation of artifacts during the preparation of LDL.
